Neurofibromatosis type 1 and cardiac manifestations.

OBJECTIVE Cardiac manifestations of neurofibromatosis type 1 (NF1) may include hypertension, congenital heart disease, and hypertrophic cardiomyopathy. The aim of this study was to evaluate cardiac abnormalities in patients with NF1. METHODS Sixty-five NF1 patients (mean age: 9±4.48 years) were retrospectively studied. Standard electrocardiography and echocardiography were performed in all patients. RESULTS Cardiac abnormalities were found in 11 of the 65 patients (15.3%). Five patients had mitral valve regurgitation, 2 patients had secundum atrial septal defect, 1 patient had pulmonary valvular stenosis, 1 patient had ventricular septal defect, 1 patient had tricuspid valve regurgitation, and 1 patient had aortic valve regurgitation. CONCLUSION Cardiac abnormalities have potential long-term hemodynamic consequences that justify an early diagnosis. Thus, for any patient with NF1, a cardiologic assessment is mandatory at the time of diagnosis and with regular follow-up intervals.

[1]  G. Di Salvo,et al.  Blood pressure and cardiovascular involvement in children with neurofibromatosis type1 , 2004, Pediatric Nephrology.

[2]  B. McManus,et al.  Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force , 2002, Genetics in Medicine.

[3]  G. Di Salvo,et al.  The heart in neurofibromatosis type 1: an echocardiographic study. , 2002, American heart journal.

[4]  C. Romano,et al.  Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. , 2000, American journal of medical genetics.

[5]  B. Garicochea,et al.  Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia. , 1998, Leukemia research.

[6]  P. John,et al.  Hypertension secondary to progressive vascular neurofibromatosis , 1997, Archives of disease in childhood.

[7]  P. Gasparini,et al.  Screening of neurofibromatosis type 1 gene: identification of a large deletion and of an intronic variant , 1995, Clinical genetics.

[8]  D. Gutmann,et al.  Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle , 1995, Neurobiology of Disease.

[9]  N. Copeland,et al.  Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. , 1994, Genes & development.

[10]  V. Riccardi,et al.  Type 1 neurofibromatosis and the pediatric patient. , 1992, Current problems in pediatrics.

[11]  J. Charrow,et al.  Neurofibromatosis type 1 in childhood. , 1990, The Journal of pediatrics.

[12]  A. Tajik,et al.  Hypertrophic obstructive cardiomyopathy and lentiginosis: a little known neural ectodermal syndrome. , 1981, The American journal of cardiology.